We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LBIRD.PA

Price
9.00
Stock movement down
-0.06 (-0.66%)
Company name
Lumibird SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Diagnostics & Research
Market cap
198.09M
Ent value
355.52M
Price/Sales
0.65
Price/Book
1.02
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
28.27
Forward P/E
15.52
PEG
-
EPS growth
-8.95%
1 year return
-35.48%
3 year return
-24.42%
5 year return
-1.87%
10 year return
10.48%
Last updated: 2025-04-12

DIVIDENDS

LBIRD.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E28.27
Price to OCF5.12
Price to FCF-
Price to EBITDA3.98
EV to EBITDA7.15

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.65
Price to Book1.02
EV to Sales1.17

FINANCIALS

Per share

Loading...
Per share data
Current share count22.01M
EPS (TTM)0.32
FCF per share (TTM)-0.13

Income statement

Loading...
Income statement data
Revenue (TTM)302.80M
Gross profit (TTM)77.98M
Operating income (TTM)20.72M
Net income (TTM)7.01M
EPS (TTM)0.32
EPS (1y forward)0.58

Margins

Loading...
Margins data
Gross margin (TTM)25.75%
Operating margin (TTM)6.84%
Profit margin (TTM)2.31%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash63.87M
Net receivables42.81M
Total current assets200.95M
Goodwill73.13M
Intangible assets62.83M
Property, plant and equipment0.00
Total assets414.82M
Accounts payable20.63M
Short/Current long term debt153.90M
Total current liabilities75.11M
Total liabilities221.31M
Shareholder's equity193.51M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)38.65M
Capital expenditures (TTM)41.55M
Free cash flow (TTM)-2.90M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity3.62%
Return on Assets1.69%
Return on Invested Capital3.32%
Cash Return on Invested Capital-1.37%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open9.14
Daily high9.16
Daily low8.94
Daily Volume3K
All-time high25.65
1y analyst estimate12.20
Beta1.37
EPS (TTM)0.32
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
LBIRD.PAS&P500
Current price drop from All-time high-64.92%-12.89%
Highest price drop-95.44%-56.47%
Date of highest drop16 Dec 20139 Mar 2009
Avg drop from high-62.20%-11.07%
Avg time to new high260 days12 days
Max time to new high4858 days1805 days
COMPANY DETAILS
LBIRD.PA (Lumibird SA) company logo
Marketcap
198.09M
Marketcap category
Small-cap
Description
Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two segments, Photonics and Medical. The company offers solid-state and diode lasers, fiber lasers, fiber lasers/amplifiers and components, Laser rangefinder and LiDAR wind doppler LiDAR, medical and ophthalmological equipment. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The company was incorporated in 1970 and is headquartered in Lannion, France.
Employees
1053
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The European market has recently seen a modest uptick, with the pan-European STOXX Europe 600 Index rising by 0.56%, driven by hopes of increased government spending, although concerns over proposed U...
March 27, 2025
Lannion, March 21, 2025– 5:45pm LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2025 LUMIBIRD’s shareholders are informed that they are invited to take part in ...
March 21, 2025
Lannion, 11/03/2025 – 5:45pm ANNUAL RESULTS 2024 EBITDA margin(1) of 15.9%, of which 20.6% for the Medical division and 10.8% for the Photonics divisionStrong growth in the 2nd half with 20.2% EBITDA ...
March 11, 2025
Lannion, 27/01/2025 - 5.45pm LUMIBIRD: 2024 SALES AT €207.1M (+1.7% -REPORTED) Medical Division: €107.7m (+4.8% on a reported basis), a recovery confirmed by a new record for billings in Q4 of €33.5m ...
January 27, 2025
Lannion, January 24, 2025 FINANCIAL COMMUNICATIONS AGENDA LUMIBIRD [FR0000038242 – LBIRD], the European leader for laser technologies, publishes its financial communications agenda for 2025. Disclosur...
January 24, 2025
Lannion, November 27, 2024 – 8:00 am LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION Following market rumours, Lumibird (FR0000038242 - LBIRD) confirms that it is currently exploring the po...
November 27, 2024
Lannion, October 21, 2024 – 5:55 pm Q3 REVENUEAGREEMENT SIGNED TO ACQUIRE THE CONTINUUM PRODUCT RANGE FROM THE AMPLITUDE LASER GROUP Growth upturn in Q3 for the Medical Division, stability for the Pho...
October 21, 2024
Lannion, October 15, 2024 – 17:45 pm LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M 55.2m repayable over 7 years, to reschedule existing loans50m to be dra...
October 15, 2024
Lannion, September 24, 2024 – 17:45 pm FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISION EBITDA1 of €10.9m on a reported basis, compared with €13.8m in H1 2023 Me...
September 24, 2024
The European economy has recently seen a boost from the Paris Olympics, with France's CAC 40 Index gaining 1.71%, reflecting broader market optimism driven by potential interest rate cuts from both th...
August 26, 2024
Next page